Picardi, M., Della Pepa, R., Giordano, C., Zacheo, I., Pugliese, N., Mortaruolo, C., . . . Pane, F. (2019). Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL. Blood.
Chicago Style CitationPicardi, Marco, et al. "Tenofovir Vs Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Advanced-stage DLBCL." Blood 2019.
Cita MLAPicardi, Marco, et al. "Tenofovir Vs Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Advanced-stage DLBCL." Blood 2019.
Atenció: Aquestes cites poden no estar 100% correctes.